Science & Enterprise subscription

Follow us on Twitter

  • Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
    about 9 hours ago
  • New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
    about 9 hours ago
  • Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
    about 3 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Commentary – Scott Gottlieb’s Legacy

Scott Gottlieb

During his tenure, FDA issued a number of guidance documents outlining regulatory processes and practices that streamline reviews, yet are still dictated by scientific evidence. . . . → Read More: Commentary – Scott Gottlieb’s Legacy

Insulin Delivered by Capsule, That’s the Good News

Diabetes word cloud

Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin. . . . → Read More: Insulin Delivered by Capsule, That’s the Good News

Book Review – The Fifth Risk

The Fifth Risk cover

Michael Lewis describes in a gripping narrative some of those critical life-protecting functions the federal government performs in his new book The Fifth Risk. . . . → Read More: Book Review – The Fifth Risk

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

You Call That a Drug Pricing Policy?

Pills on money

Although he called it, “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan was anything but that. . . . → Read More: You Call That a Drug Pricing Policy?

Drug Price Report Calls for Govt Negotiation, More Generics

A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers. . . . → Read More: Drug Price Report Calls for Govt Negotiation, More Generics

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Immigration Crackdown “a Disaster” for U.S. Science

A panel of research executives from American universities said the current hostility to immigration in the U.S. is causing fear among many researchers and could have a serious impact on science. . . . → Read More: Immigration Crackdown “a Disaster” for U.S. Science

Precision Medicine, “My Hope for the Future”

A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure. . . . → Read More: Precision Medicine, “My Hope for the Future”